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Abstract
Background: Nephropathy is one of the complications of type 2 diabetes mellitus that could lead to end‑stage renal 
disease. Persistent microalbuminuria is the best predictor of high risk of developing diabetic nephropathy. The relation 
between HbA1c and microalbuminuria with the duration of diabetes is not clear.
Objectives: To determine microalbuminuria levels in type 2 diabetics and to correlate changes in microalbuminuria 
levels to glycosylated hemoglobin level and duration of diabetes.
Materials and Methods: Study was conducted at Medical College, Kolkata. Fifty both male and female type 2 diabetics 
of age groups 30‑60 years, without any complications were taken as cases and 50 healthy (male and female) subjects 
of comparable age were taken as controls. Cases with anemia, any other diseases or person using drugs that could 
affect HbA1c levels and microalbuminuria were excluded from the study. Fasting and postprandial blood glucose, HbA1c 
serum urea and serum creatinine were analyzed. Urine was analyzed for microalbuminuria. The Statistical Software 
SPSS 15.0 were used for the analysis of the data.
Results: Urinary microalbumin, HbA1c levels were significantly higher in the cases. Microalbumin levels were linearly 
correlated to the duration of diabetes and HbA1c.
Conclusions: Impaired glycemic control is associated with significant elevations in urinary microalbumin levels. 
Furthermore, there is an increased urinary microalbumin levels with increased duration of diabetes, which suggests that 
the detection of increased urinary microalbumin levels at the initial stage can avert, reduce the clinical and economic 
burden of diabetic complications in future.
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Introduction
Diabetes mellitus is the leading cause of end‑stage renal 
disease (ESRD) in several countries.[1] It is also the cause 
of chronic hemodialysis and renal transplantation. Several 
studies have suggested that detection of early changes in 
renal function via microalbuminuria tests prevent further 
progression of the disease.[2‑5] Microalbuminuria is common 
(prevalence rates of 10‑48%) and is a well‑established risk 
factor for macrovascular diseases in type 2 diabetics. 
Microalbuminuria defined as urinary albumin excretion 
rate of 20‑200 µg/min or urinary protein excretion rate 
of 30‑300 µg/min predicts future development of overt 
nephropathy.[6] As microalbuminuria can be reversed and 
the future development of overt diabetic nephropathy 
significantly reduced, screening for microalbuminuria 
and timely therapeutic intervention has become standard 
of care worldwide. Microalbuminuria is also considered 
to be a predictor for cardiovascular disease both among 
diabetic and non‑diabetic subjects,[7,8] and is one of the 
Relation of microalbuminuria to glycosylated 
hemoglobin and duration of type 2 diabetes
D Kundu, A Roy1, T Mandal, U Bandyopadhyay2, E Ghosh3, D Ray
Department of Biochemistry, Medical College, Kolkata. 1Department of Physiology, R.G. Kar Medical College, 2Department 
of Pathology Medical College, College Street, 3Department of Anatomy, R. G. Kar Medical College, Kolkata, 
West Bengal, India






217Nigerian Journal of Clinical Practice • Apr-Jun 2013 • Vol 16 • Issue 2
Kundu, et al.: Relation of microalbuminuria to glycosylated hemoglobin and duration of type 2 diabetes
components of the metabolic syndrome (insulin resistance 
syndrome).[4,9] Microalbuminuria (MAU) represents the 
simplest and most sensitive prognostic factor to evaluate 
the risk of overt nephropathy in diabetes, representing 
the first stage of progressive diabetic renal disease.[10] 
However, it is not clear whether MAU represents an 
independent predictor or rather a marker of organ 
damage, since mechanisms linking MAU with end‑organ 
damage have not been fully explained.[11] HbA1c is a blood 
glucose control marker in diabetic patients. Glycosylated 
hemoglobin (HbA1c) results from post‑translation changes 
in the hemoglobin molecule, and their levels correlate 
well with glycemic levels over the previous six to ten 
weeks. Glycosylation of hemoglobin takes place under 
physiological condition by a reaction between glucose and 
N‑terminal valine of beta chain of molecules.[12] Higher 
levels of HbA1C were associated with increased risk for 
development of microangiopathy in diabetic. This may be 
due to the fact that HbA1c has special affinity for oxygen 
thereby causing tissue anoxia and plays a role in causation 
of micro and macroangiopathy.[13] Several studies have 
shown a positive correlation between microalbuminuria 
and HbA1c.
[14‑17] However, this has not been established. 
These findings become an important and an interesting 
aspect for a detailed study.
Materials and Methods
Study was conducted at Medical College, Kolkata. Usual 
permission from ethical committee and consent from 
subjects and controls were taken before commencing 
the study. Fifty both male and female type 2 diabetics 
of age groups 30‑60 years, without any complications 
were taken as cases and 50 healthy (male and female) 
subjects of comparable age were taken as controls. Cases 
with anemia, any other diseases or person using drugs 
that could affect HbA1c levels and microalbuminuria were 
excluded from the study. 0.5 ml of venous sample was 
collected from the subjects. The samples were centrifuged, 
separated and stored at 4°C until analysis. The blood 
samples were analyzed for HbA1c (immuno‑inhibition 
method),[18] fasting blood glucose and postprandial blood 
glucose (GOD‑POD),[19] serum urea (urease method)[20] 
and serum creatinine (Jaffe’s Kinetic).[21] Urine sample 
was analyzed for microalbumin (immunoturbidimetric 
method).[22]
Statistical analysis
Student’s t test has been used to find the significance of study 
parameters on continuous scale between two groups and to 
test the homogeneity samples based on age (or continuous 
parameters) and Chi‑square test to test the homogeneity of 
samples based on parameters on categorical scale between 
two groups. Pearson correlation between duration and 
microalbumin is computed to find the relationship. The 
Statistical Software SPSS 15.0, Stata 8.0, MedCalc 9.0.1 
and Systat 11.0 were used for the analysis of the data and 
Microsoft Word and Excel have been used to generate 
graphs and tables.
Results
Mean levels of biochemical parameters are represented in 
Table 1. Levels of Fasting Blood Glucose (FBG), Post‑prandial 
Blood Glucose (PPBG), Glycosylated Hemoglobin (HbA1c), 
Microalbumin, Serum Urea and Serum Creatinine were 
found to be higher in cases compared with controls and found 
to be statistically significant (P < 0.001). Microalbumin 
levels in relation to duration of type 2 diabetes were 
represented in Table 2. Microalbumin levels (g/day) were 
found to be highest i.e., 0.449 ± 0.160 g/ day in diabetic 
subjects with duration of diabetes more than four years, 
statistically significant (P < 0.001). The correlation graph 
of microalbumin levels to duration of diabetes is depicted 
in Graph 1. The correlation graphs of microalbumin levels 
to HbA1c in controls and cases are depicted in Graphs 2 
(r = 0.451; P = 0.046) and 3 (r = 0.609; P = 0.004), 
respectively Graph 3.
Discussion
FBG, PPBG values are higher in type 2 diabetics and are 
statistically significant (P < 0.001). Serum urea and serum 
creatinine were found to be higher in type 2 diabetics 
compared with controls and is statistically significant in 
cases (P < 0.001). Measurement of HbA1c is used in the 
long‑term monitoring of DM. The level of HbA1c has 
been widely accepted as an indicator of mean daily blood 
glucose concentration over the preceding 8–12 weeks. In 
the present study, levels of HbA1c are higher in diabetics 
than in controls, and the elevations are of high statistical 
Table 1: Mean levels of biochemical parameters
Parameters Controls Cases P value
FBG (mg/dl) 91.00±10.01 174.15±69.74 <0.001
PPBG (mg/dl) 119.40±21.16 221.75±74.12 <0.001 
HbA
1c
 (%) 5.04±0.48 7.87±1.72 <0.001
Microalbumin (mg/day) 3.28±2.02 292.95±156.45 <0.001
Urea (mg/dl) 24.55±8.09 43±20.68 <0.001
Creatinine (mg/dl) 0.96±0.22 1.24±0.58 0.055
Table 2: Microalbumin in relation to duration of 
diabetes (in years)
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significance (P < 0.001). In this present study, it is found 
that diabetics with poor glycemic control had higher 
microalbumin levels compared with those of diabetics with 
good glycemic control, and this finding is in agreement 
with several other studies.[16,17,23,24] This study also 
highlights that there is a significant correlation between 
microalbumin levels and HbA1c in cases. Studies have 
confirmed that there is an association of microalbumin 
levels with well‑established risk factors such as age and 
poor glycemic control (HbA1c). Similarly, the present 
study reveals that the diabetics’ subjects having poor 
metabolic control are more prone to renal damage, and 
thus elevated microalbumin levels. Microalbumin levels 
are found to be higher in cases than in controls, and are 
found to be statistically significant (P < 0.001). The 
increased microalbumin levels in diabetic subjects may 
be due to an altered glomerular filtration barrier, at the 
podocyte level. Damage to the podocyte may be explained 
by the fact that there is an increase in the extracellular 
release of reactive oxygen species.
This study reveals that the mean value of microalbumin 
is more in males compared with females. This finding is in 
agreement with several other findings.[15,25,26] In the present 
study, no statistical correlation was found between the levels 
of microalbumin and between the ages of patients and is in 
agreement with previous studies.[27,28] In the present study, a 
good statistically significant correlation was found between 
the prevalence of microalbuminuria and duration of diabetes 
that was consistent with findings of past studies. [15,29‑31] 
Our findings are in correlation with the findings of several 
other studies. Several studies on regression analysis and 
diabetes duration were identified as a strong predictor 
for the development of abnormal albuminuria in type 2 
diabetes mellitus. Our study also shows that duration of 
diabetes is a strong predictor of increased microalbumin 
excretion. Previous studies in type 2 diabetics indicate 
that proteinuria and renal failure are common.[32] This 
signifies that as the duration of diabetes increases, the GFR 
(Glomerular Filtration Rate) decreases. Some studies have 
detected enlarged kidney in diabetics of less than 2 years 
of duration.[33‑35]
Further studies on this aspect also gave the impression 
that enlarged kidney is not a common feature of type 2 
diabetes mellitus.[36] The reasons for this apparent lack 
of enlarged kidney in type 2 diabetes mellitus could be 
two‑fold; firstly, the onset of type 2 diabetes cannot be 
pinpointed with accuracy, as it may be preceded by a 
variable period of asymptomatic hyperglycemia of 5‑7 years. 
During this period of asymptomatic hyperglycemia, the 
patient may have an enlarged kidney, which by the time 
of detection of diabetes may have regressed to the normal 
size or may even have contracted as a result of the ongoing 
destruction. Secondly, type 2 diabetes mellitus is the disease 
of the elderly, and age‑related phenomenon might have a 
bearing on the kidney function. Generalized arteriosclerotic 
changes, decreased vascularity, concomitant hypertension 
or the presence of other non‑diabetic renal diseases can 
also lead to a decrease in kidney function and size. The 
functional abnormality concomitant with enlarged kidney 
is hyper‑filtration and intra‑renal hypertension, which 
have been originally proposed to the off‑key pathogenetic 
significance by a particular study.[37] So, it may be reported 
that proteinuria develops more frequently in subjects 
Graph 1: Correlation of microalbumin levels to duration of type 2 
diabetes
Graph 3: Correlation of Microalbumin levels to HbA1c in cases
Graph 2: Correlation of microalbumin levels to HbA1c in controls
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with diabetes of long duration, poor glycemic control and 
albuminuria.
In type 2 diabetic patients, the duration of diabetes was the 
strongest predictor and elevated glycemic control (HbA1c) as 
well predicted increased microalbumin excretion rate. So, it 
may be suggested that determination of microalbumin levels 
in urine is an easy method of screening diabetic patients, 
especially diabetic patients with long‑term diabetes. It is 
further suggested screening for microalbuminuria in diabetic 
patients in order to reduce future kidney disease. From this 
study, it seems that if good glycemic control is maintained at 
early stages of diabetes, chances of microalbuminuria is less.
Despite its devastating consequences, microalbuminuria 
is still a largely unrecognized risk factor, and a large 
proportion of individuals with diabetes are not regularly 
screened. There are several limitations to this study that 
needs to be discussed. Firstly, this was a cross‑sectional 
study and for this reason, it is not possible to establish a 
firm cause‑effect relationship between the risk factors 
identified, their interaction and MAU. Secondly, although 
the measurements of urinary MAU were centralized, we 
obtained only one measurement of the microalbumin. 
Finally, the sample size (the number of cases) is so 
small that these results cannot be applied to the whole 
population of individuals suffering from type 2 diabetes 
mellitus. Despite its role as an independent predictor of 
renal and cardiovascular outcomes, the importance of 
monitoring microalbuminuria (MAU) and to act as a 
modifiable risk factor is still underestimated. Therefore, 
large‑scale clinical trials to establish a relation between 
elevated microalbumin levels and type 2 diabetes mellitus 
are worth undertaking.
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